Learn how to track and trace your samples at the Emerald Scientific booth!
Come see @Emerald Scientific April. 1-3 at the 9th Annual Emerald Conference at the Loews Coronado Bay, San Diego, CA. Register for the conference now at https://bit.ly/43B8T8I Drop by TABLE #3 to meet our amazing team members! Can't make it to the show? Visit our website to see our latest products here: https://bit.ly/3xdfVV9 #emeraldscientific #emeraldconference #sandiego #cannabisconference
Laboratory Relocation Specialist. Project Managing and Relocating Laboratories. Completing Storage and Distribution of Laboratory Equipment and Consumables. HTA regulated sample storage and disaster recovery solutions
Great to see some of the Restore Harrow Green Laboratory Services team out and about again! Have a chat with these two and find out how we can assist you with your laboratory project management planning, relocation and storage needs. #pharma #researchanddevelopment #logistics #projectmanagement #lifesciences
Your personalised, comprehensive & managed solution for relocating, moving, furniture, recycling & storing 🚛📦 ♻️
Bionow BioInfect 2024 🔬👨🏼🔬 Catch myself & Sean Leslie 🧬🧪 at todays event - here to talk about your laboratory requirements and plans. Dave Shewring 🧪🔬 Tyler Doherty Will King Martin Paul Steven Hall Karl Crompton Paul Bray Habeeb Alao MSc🧪🔬⚗️🧬 Lynn Thomson Julie Gubbay Patrick Zeall Ashley Ward Andy Chatt
Introducing the new Ovesco Scientific Newsletter: The latest clinical data in a compact format We would like to inform you about the new format of the Ovesco Scientific Newsletter. Its new structure is compact and clear. Thereby you can capture the relevant information more quickly, saving you valuable time in your day-to-day clinical work. Not yet a subscriber? Click here to subscribe and stay up to date with relevant clinical data on our products and procedures: https://lnkd.in/d3cVJxm #ovesco #sis #scientificnews
▪ It was great to catch up with old friends and colleagues, seeing them now in these positions of influence, hugely successful careers, taking ownership, protecting our two-legged and four-legged public. ▪ It was great to connect with FDA in this relaxed setting - instead of during an inspection or regulatory meeting! 😉 ▪ It was also great to meet folks for the first time! The networking opportunities were great, though I did miss quite a few of you! A few take-aways: 🔹 Basic, fundamental GMP issues continue to be seen by FDA across the industry, despite the tools, technology, resources, policy, guidance documents, history of observations, warning letters and enforcement, training, industry groups. 🔹 Bare feet in an ISO-classified suite?!?! 🔹 FDA’s Top Ten Issues cited in 483s have not really changed over 20+ years; rankings have shifted up or down, but it is still the same things 🔹 Similarly, DI (data integrity) is not a new concept. As Dr. Cavazonni said, “Get away from paper.” 🔹 “Reading an SOP is not training” – Alonza Cruse 🔹 “The battle is won and lost at the Supervisor level” – Kevin O’Donnell, (HPRA) 🔹 Have we forgotten about the patient? Have we forgotten who the patient is? Do we not realize we are The Patient? 🔹 “Cost of Quality” Why do we use this term? Why don’t we ever speak of the Cost of HR? The Cost of Supply Chain? of Technical Services? 🔹 Leadership sets the tone: it is the determiner of success. 🔹 Leadership is responsible for issues – whether they know it, or not. 🔹 Training, training, training. Real, intentional, training. Designing your org to be effective over the product life cycle should be your goal, not just for the next quarter’s results. Isn’t there a company out there that can help with this? 🔷 Eliquent – from thought to finish 🔷 Christie Bielinski; Karin Baer; Ileana Barreto-Pettit; Linda Evans O'connor;William (Al) Kentrup; Gerard (Jerry) Greco; Donald Ashley; Grace McNally ; Barbara Clendenen; Carmen C. Araujo; Elaine Shannon; Magaly Aham, MSc, RAC-US; Christina M. Mazzella; Domenic Veneziano; Sumaiya Reza; Zhenzhen Liu; Arlene Wolny; Arie Menachem; Saundrea Munroe; Jerome Chal; Maria McCaffrey; Cathy Burgess; Beth Weinman; Greg Levine ; Darrin Schellin; Brendan Carroll; Ben Wolf; Anthony Fanucci, PharmD, JD; Quality & Regulatory Network; Alonza Cruse; Michelle Toro, ASQ CQA, CSQP; Judy Zdanowicz; ELIQUENT Life Sciences; Eliquent Japan, Inc; Eli Shani; Ori Landau; Kimberly Garko; Jenna McCarthy
Members of the ELIQUENT Life Sciences team - Donald Ashley, Grace McNally, and Joseph Jimenez - will be at this week's annual PDA-FDA Joint Regulatory Conference. Stop by our booth and learn more about ELIQUENT's unique platform delivering full-service support for life science innovators. ELIQUENT.com
Have your voice heard as we discuss important issues in the bioscience sector!
Join us in Topeka for the annual Bioscience Day at the Capital! Meet Kansas' elected officals and advocate for your company's needs. Register for this free event here: https://ow.ly/1RkY50Qrpzu
#polishbiotech at #Bio2024 Meet CLINMARK - Clinical Research and Consulting at Polish National Pavilion #4049 organised by Polish Investment and Trade Agency (PAIH) & Związek BioForum to talk about clinical validation of your innovative drug or medical device 🤝 #clinicaltrials #innovation
🌟 Exciting News! 🌟 We're thrilled to announce that Jacek Banach, MBA will be representing ClinMark at the upcoming BIO San Diego International Convention! 🚀 Jacek is eager to connect with fellow industry professionals and share insights on the latest advancements in clinical research. Don’t miss the chance to meet him and explore how ClinMark's tailored approach and global reach can support your research goals. 🗓 Date: 3-6 June 📍 Location: #4049 Polish Investment & Trade Agency Be sure to stop by and say hello! #BIOSanDiego #SanDiegoConvention #ClinicalResearch #Networking #ClinMark #IndustryLeadership #PolishInvestmentandTradeAgency #CebioForum
🎙️The final episode of #RBDCOVTalks is out 🎙️ Laura SesmaI from Zabala Innovation Europe discusses the importance of responsibility & collaboration in European projects, such as RBDCOV_EU! Tune in & learn more about the next steps of this project, where EATG plays a pivotal role.⬇️
🎙️🙌 The final episode of #RBDCOVTalks is here! Explore #RBDCOV's clinical trial results, its main findings & our next steps. 💉 Laura Sesma Aguirre from Zabala Innovation Europe will guide us on the importance of responsibility & collaboration in European projects. 🌎 👉🔴 https://lnkd.in/djV7fxsM
September 26-27 is coming and #BioBridges2024 will have again exciting speakers and program. Should you wish to learn more visit us at biobridges.eu and get inspired also by our Archive section containing presentations from our past years 2016-2023. Last year was fun, with rich scientific content and relaxing networking dinner. #BioBridgesConference has covered: M13 guideline series: status update, Susana Almeida and Volodymyr Stus and Mary Malamatari Tmax/pAUCs, Jiri Hofmann and Tadalafil Tmax – case study, Paolo Biffignandi pAUCs and clinical relevance for LALA, Vit Perlik NTIs, Paulo Paixao Current thinking of a tailored clinical approach in biosimilars, Rene Anour Equivalence for lozenges: in vitro in vivo and link between both, Jean-Michel Cardot Detection of data manipulation in bioequivalence trials, Anders Fuglsang Sex– and group-related problems in BE – a delusion, Helmut Schutz Comparison and interpretation of dissolution time profiles of oral tablets, Stefan Horkovics-Kovats RWE – real world evidence/RWD real world data, Steffen Thirstrup and Mariusz Mogielnicki Well-established use – case studies, Jana Klimasova Hybrid as registration route for alternative formulations and posologies to increase patient comfort/adherence, Paula Muniz
See you there, if you want to learn more about the myeloid cell "mess" and how to target it in fibrotic diseases.
📣 With 𝗹𝗲𝘀𝘀 𝘁𝗵𝗮𝗻 𝟮 𝘄𝗲𝗲𝗸𝘀 𝘁𝗼 𝗴𝗼, limited places remain for the 𝟴𝘁𝗵 𝗜𝗣𝗙 𝗦𝘂𝗺𝗺𝗶𝘁 (August 20-22, Boston). This gathering is more than just a conference, but a crucial opportunity for the IPF community to come together, share insights, and collaborate on the challenges faced in advancing the field. From exploring novel targets to the latest updates from promising clinical trials, exploring new endpoints and discussing patient-centered outcomes, this summit is designed to spark the important discussions that will shape the future of IPF research and drug development. Explore the full list of what’s in store on the full event guide here: https://ter.li/r7shqs Don’t miss out on these progressive conversations and opportunity to build connections and collaborations essential for driving progress turning scientific discoveries into meaningful clinical advancements! You can secure your pass here: https://ter.li/cpcvjd 🙌 A huge thank you to our expert speaker faculty: Adam Freund, Aditya Patel, Ahmed Mousa, Amy Case, Professor Bertil E. Lindmark, Brian Windsor, Kotton, Darrell, David Lagares, David Rowlands, Diana Julie Leeming, Elaine Kilgour, Farida Ahangari, Fernando Martinez, Gregory Cosgrove, Henrik Landgren, Imran Alibhai, Imre Noth, Ines Macias-Perez,, Jason McCarthy,, Jeffrey Bornstein, Jim Wu, Joe GN "Skip" Garcia,, Katie M., Kjetil Ask, Lee Borthwick, Lida Hariri, Margaret Salisbury, marilyn glassberg, Matthew Thomas, Michael Foley, Peter George, Peter Smith, Piet Wigerinck, Simon LF Walsh, Thomas Fabre, Toby Maher, Vipin Kumar, Zbigniew Zaslona Looking forward to seeing everyone there and continuing these vital conversations! 🤝 #IPFSummit #PulmonaryResearch #IPFCommunity #DrugDevelopment #PatientCenteredCare #IPF #ILD
Innovative Business Development Manager | 13+ Years in Clinical Trials | Diversity Advocate | Disrupting the Industry Status Quo | CRIO Employee, Opinions my own
The proof is in the pudding. Or in this case the study metrics! CRIO sites enrolled 42% more patients per site. CRIO sites screened patients 31 days faster on average. CRIO sites enrolled patients 44 days faster on average. CRIO sites had 21% fewer major protocol deviations per enrolled patient. CRIO sites achieved a 5% higher patient retention rate. Why would you not want to book a meeting with me now? 😂 #clinicaltrials #innovation
In our newest blog post, we partnered with Sitero to dive into a comprehensive case study of a phase 3 trial involving 140 research sites across Australia, Canada, and the United States, comparing the performance of sites using CRIO’s eSource platform with those that aren't. From improved enrollment efficiency to a reduction in protocol deviations, CRIO’s technology is transforming the way clinical trials are conducted, leading to more reliable and timely results. If you’re involved in clinical research and looking to optimize your trials, this blog post is a must-read. 🔗: https://bit.ly/4gq6GCT
Managing Partner at LeapAhead Solutions | Optimizing Life Science Regulatory Affairs, Clinical Operations and Quality including AI / Automation and Data Strategy and Governance
SAVE THE DATE for DIA's Regulatory Information Management (#rim) Community All-Hands Meeting on Thursday, April 4 at 12 PM ET where we will learn about the RIM Reference Model and how to apply it to our #regulatory information to simplify internal and external #dataexchange. DIA members can find the webinar details (including the link to join) here: https://lnkd.in/eWwNeKhh. John Jones, Vanessa Brewer-Yizar, Patterson (Pat) Shafer and I look forward to seeing you there! #diarim #datagovernance #dataquality #pharma #biotech #regaffairs